Publications by authors named "Prajish Iyer"

Claim this Profile
S
SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway.
Bo Zhang, Prajish Iyer, Meiling Jin, Elisa Ten Hacken, Zachary J Cartun

JCI Insight· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated SF3B1-K700E mutation controls immune responses by regulating T function via aberrant splicing.
Yun Shi, Wencan Zhang, Qiong Jia, Xiancai Zhong, Prajish Iyer

Sci Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
deletion leads to Richter's transformation by modulating mitochondrial OXPHOS.
Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Hart

Sci Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.
Martina Cusan, Haifeng Shen, Bo Zhang, Aijun Liao, Lu Yang, Prajish Iyer

J Clin Invest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling ATF6 and PPM1H signaling in hepatocellular carcinoma progression: From ER stress to tumor suppression.
Prajish Iyer, Shivangi Oberai, Brian Jiang, David Marimekala

Mol Ther Nucleic Acids· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Therapies in CLL in the Era of Precision Medicine.
Prajish Iyer, Lili Wang

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
deletion leads to Richter's transformation via modulation of mitochondrial OXPHOS.
Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Hart

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations.
Asim Joshi, Rohit Mishra, Sanket Desai, Pratik Chandrani, Hitesh Kore, Prajish Iyer

Oncotarget· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of SETMAR-H3K36me2-NHEJ repair axis in residual disease cells prevents glioblastoma recurrence.
Ekjot Kaur, Jyothi Nair, Atanu Ghorai, Saket V Mishra, Anagha Achareker, Prajish Iyer

Neuro Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Prajish Iyer, Shailesh V Shrikhande, Malika Ranjan, Asim Joshi, Nilesh Gardi

Int J Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMC-SNPdb: an Indian germline variant database derived from whole exome sequences.
Pawan Upadhyay, Nilesh Gardi, Sanket Desai, Bikram Sahoo, Ankita Singh, Prajish Iyer

Database (Oxford)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-typhoidal Salmonella DNA traces in gallbladder cancer.
Prajish Iyer, Savio George Barreto, Bikram Sahoo, Pratik Chandrani, Mukta R Ramadwar

Infect Agent Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated genomics approach to identify biologically relevant alterations in fewer samples.
Pratik Chandrani, Pawan Upadhyay, Prajish Iyer, Mayur Tanna, Madhur Shetty

BMC Genomics· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis